US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Contineum Therapeutics Inc (CTNM)
Contineum Therapeutics Inc (CTNM) ニュース

CTNM

Contineum Therapeutics (CTNM)

Contineum Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTNM

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/09	06 : 05	Business Wire	Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)	NASDAQ:CTNM	Contineum Therapeutics Inc
2025/01/06	22 : 00	GlobeNewswire Inc.	RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/12/17	06 : 05	Business Wire	Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/28	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/25	22 : 05	Business Wire	Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/21	07 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/19	07 : 05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/18	22 : 05	Business Wire	Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/14	06 : 05	Business Wire	Contineum Therapeutics to Attend Upcoming Investor Conferences	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06 : 05	Business Wire	Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/29	05 : 05	Business Wire	Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	07 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	01 : 46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	01 : 19	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/14	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/14	05 : 05	Business Wire	Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/01	05 : 05	Business Wire	Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/25	05 : 05	Business Wire	Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/05	05 : 05	Business Wire	Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	06 : 43	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	05 : 05	Business Wire	Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/01	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/21	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/21	05 : 05	Business Wire	Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors	NASDAQ:CTNM	Contineum Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:CTNM

African Development Bank

NLBNPIT1Z5W5 20351221 50...

Vontobel Financial Produ...

Zapata Computing

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約